Keywords: Parkinson's Disease, Perfusion
Motivation: Reliance on neuropsychological testing for diagnosing Parkinson’s disease with mild cognitive impairment (PD-MCI) is limited by expert availability. Understanding brain correlates with cognitive impairments may provide alternative diagnostic tools to better understand PD-MCI.
Goal(s): Determine whether arterial transit time (ATT) and cerebral blood flow (CBF) can distinguish PD-MCI from PD with normal cognition (PD-NC).
Approach: A cross-sectional study compared ATT and CBF across PD-MCI, PD-NC, MCI, and healthy controls (HC) and analyzed correlations with clinical variables.
Results: Higher ATT and lower CBF were observed in PD-MCI that correlated significantly with clinical scores suggesting potential for fMRI-based diagnosis of PD-MCI.
Impact: This study demonstrates the potential of ATT and CBF as neuroimaging biomarkers for diagnosing mild cognitive impairment (MCI) in Parkinson’s disease (PD). These findings highlight the promise of ATT and CBF in enabling early and accurate cognitive assessment of PD-MCI.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords